2013 ATPAC Annual Meeting Thailand-U.S . Cooperation: From R&D to Commercialization August 29 , 2013 Bangkok, T

1. 2013 ATPAC Annual Meeting Thailand-U.S. Cooperation: From R&D to Commercialization August 29 , 2013 Bangkok, Thailand Thailand and S&T Related Venture Capital Noppawan Tanpipat, Ph.D. Vice President, Innovation Strategy and Partnering PTT Global Chemical Public Company Limited (PTTGC)

2. Agenda • Agenda • PTTGC Business Overview • A result entity of amalgamation • Product portfolio and global business • PTTGC strategic approach to technologies • Focus of corporate venture capital in innovation process

3. Agenda • Agenda • PTTGC Business Overview • PTTGC at a glance • Product portfolio and global business • PTTGC strategic approach to technologies • Focus of corporate venture capital in innovation process

4. ICIS Top 100 Chemical Companies Ranking of the world’s largest chemical producers (listing based on 2011 sales)

5. PTTGC: The Chemical Flagship of PTT Group PTT is the national energy company engaged in conducting an integrated petroleum and petrochemicals business with the market capitalization of US$33bn1, ranked as 95th in Fortune 100 company THE LARGEST OLEFINS PRODUCER IN THAILAND AND FIFTH IN ASIA 1 COUNTRIES OPERATING PETROCHEMICAL CAPACITY [Million tonnes per annum] 5 EMPLOYEE 3531 SALES [Billion USD] 18.6* • Polymer producer with the combined production capacity of 3,482 ktpaand products ranging from HDPE, LLDPE, LDPE, PP, PS and ABS • 7th largest aromatic producer in Asia with capacity of 3,526ktpa • First and sole producer of phenol, acetone, ACN ethylene oxide and related products in Thailand • Business partner with world’s leading companies such as LyondellBasell from Netherlands, Asahi Kasei Chemical from Japan, Sime Darby Plantation from Malaysia, Cargill from the US, and Perstorp from Sweden • Note: 1) As of 30 March 2012

6. Fully Integrated Petrochemical and Refinery Operations with Diversified Product Portfolio

7. Leading chemicals company in South-East Asia with broadest expertise in downstream derivatives

8. Diversified Product Portfolio and End Markets

9. Agenda • Agenda • PTTGC Business Overview • PTTGC at a glance • Product portfolio and global business • PTTGC strategic approach to technologies • Focus of corporate venture capital in innovation process

10. PTTGC Strategic Direction “To be a Leading Chemical Company for Better Living” PTTGC’s Strategies Enhancing our core uplift Creating long-term value via HVS growth Emerging into green business models

11. Global Business: Asia, Europe and US

12. Global Megatrends Impacting Chemical/Plastic Industry Sustainability Energy Conservation Waste Reduction New Materials / Substitutes Convenience Monomer Polymerization/ Conversion Compounding Processing End Users “The Trends of Changing World Impact the PlasticsValue Chain in Many Aspect.” Regulations, Environment, and Health Next Billion Customers & Rise of Asian Demand Health & wellness Global Warming Transportation Urbanization

13. R&D Development Phase & Gap Science & Innovation Innovation and emerging technology acquisition arms to PTTCG PTT Chemical International Source: Modified from BCG Analysis

14. CVC Agenda “Green and Transformative”— CVC as an accelerator to growth beyond current business focus. Future business growth enabled by new technology New Technology Value creation Existing Un-Captured Captured Market

15. S&I Model To Acquire Emerging Technology Collaboration and Partnering In-house R&D Client or stakeholder views Technology Development Prototype and Trial Corporate strategy and priorities Research • Corporate venture capital (CVC) as one of strategic technology investment arms • Strategic benefits • Open “window on new technology” through venture investments. • Leverage external sources of innovation through contact with “technology-based investment bankers, entrepreneurs, scientists, deal finders and makers, consultants and network ”. • Create opportunities in joint development and become strategic partners. • Strengthen entrepreneurial companies’ product marketing through the existing corporate’s marketing experience and contacts. • Financial benefits • Shorten time and OPEX expenditure in leveraging R&D technology to be commercialized. • Minimize risk and impact from technology failure via indirect investment while managing opportunity of getting returns on investments upon exit events, such as IPOs or sales to third parties. • Potentially acquire a “right to operate (or produce)” of new and innovative processes (or products) to compete in their existing market via emerging technology. Researcher interests and views Joint Development Opportunity Direct Investment Indirect Investment VC Fund Portfolio Companies Technology Incubator Technology Platform

16. Unconventional Raw Materials Crude Oil Natural Gas PARADIGMSHIFT? RenewableResources Coal 1800 1850 1900 1950 2000 2050 Source: Adapted from BASF

17. Example: Synthetic Biology Synthetic biology: Development of new bio-synthetic route to a wide range of products Source: Technology Strategy Broad, “A synthetic biology roadmap for the UK”

18. Value Proposition by CVC In-house and Collaborative R&D Client or stakeholder views Shortcut for Risky technology development and Commercialization of new emerging innovation at reduced risk. Prototype and Trial Technology Development Corporate strategy and priorities Research Researcher interests and views Indirect Investment Portfolio Companies CVC Technology Incubator Technology Platform Joint development Strategic alliances

19. Collaboration & Partnering University Industry Government Agency

20. S&I Expansion Life Science Research Unit

21. Thank You www.pttgcgroup.com 555/1 Energy Complex, Building A, 14th – 18th Floor, VibhavadiRangsit Road, Chatuchak, Bangkok 10900 Thailand. Telephone : +66(0) 2265-8400 Fax : +66(0) 2265-8500